superdrols chemical structure is 2,17 di-methyl dihydrotestosterone. The propionate(on carbon 17) ester version of this compound was once used to treat a certain type of breast cancer, I believe it was a form that is highly estrogen sensitive, with modern science and drug development they now use drugs with a safer profile on women ,the methyl group on carbon 2 is thought to act in two different ways. 1 provided some sort of interaction decreasing aromatase activity, 2- provides steric hindrance to the 3 keto group, which in return will increase half life(by possibly decreasing transformation into a 3 OH). Half life of 2 methyl DHT is aprox 5.3 hours . superdrol has a 17 alpha methyl added, so i suspect the half life to be increased, to what degree i cant say without the data,( in some sense i wonder about cumulative toxicity on a 3 a day dose,maybe 10-15mg twice a day would be better), if available from AX, and they are willing.
here is the gc and mass spec of 2alpha methyl DHT.
The metabolism of dromostanolone (2á-methyl-5á - androstan-17â-ol-3-one) was studied in three adult volunteers after oral dose of 20 mg. Solvent extracts of urine obtained after enzyme hydrolysis were derivatized with MSTFA/TMCS and MSTFA/TMIS. The structures of intact drug and its metabolites were determined by gas chromatography/mass spectrometry (GC/MS) in electron impact (EI) mode. The major metabolite (2á-methyl-5á- androstan-3á-ol-17-one), its 3â -epimer, parent compound, and several hydroxylated metabolites including intact drug were detected by comparing total ion chromatograms of control urine with that of the administered sample. Two epimers of 2á -methyl-5á- androstan-3,17â-diol were detected using selected ion monitoring. The maximum excretion of dromostanolone and 2á-methyl-5á- androstan-3á-ol-17-one was reached in 6.2-15 hr. The half-life of intact dromostanolone was 5.3 hr. About 3.0% of the administered amount was found to be excreted within 95 hr as unchanged form